“…Thus, alternative methodologies for genotyping and correct identification should be used in addition to traditional tools. CRISPR-Cas systems have been used for identifying: (i) industrial microbes, including: Streptococcus thermophilus, Lactobacillus casei , and Lactobacillus paracasei (Horvath et al, 2008 ; Broadbent et al, 2012 ; Smokvina et al, 2013 ), (ii) food pathogens: Lactobacillus buchneri (Briner and Barrangou, 2014 ) and (iii) human pathogens: Campilobacter jejuni (Kovanen et al, 2014 ), Clostridium difficile (Andersen et al, 2016 ), Mycobacterium tuberculosis (Sola et al, 2015 ; Freidlin et al, 2017 ), Salmonella enterica (Shariat et al, 2013 , 2015 ; Bachmann et al, 2014 ; Almeida et al, 2017 ; Xie et al, 2017 ), Vibrio parahaemolyticus (Sun H. et al, 2015 ), Yersinia pestis (Barros et al, 2014 ; Xu et al, 2017 ) and Yersinia pseudotuberculosis (Koskela et al, 2015 ), among others. However, genotyping through CRISPR technologies has been seldom applied to probiotics, with few exceptions in Lactobacillus rhamnosus (Douillard et al, 2013 ) and Lactobacillus gasseri (Sanozky-Dawes et al, 2015 ).…”